Evidence map›Paper›PMID 35469111›Full record

ArticleAIDS and behavior2022

Rate and Predictors of Ineffective HIV Protection in African Men Who Have Sex with Men Taking Pre-Exposure Prophylaxis.

August Eubanks, Bakary Coulibaly, Bintou Dembélé Keita, Camille Anoma, Ter Tiero Elias Dah, Ephrem Mensah, Gwenaëlle Maradan, Michel Bourrelly, Marion Mora, Lucas Riegel and 6 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03459157 (Access to Pre-exposure Prophylaxis for Men Who Have Sex With Men), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03459157 nacompletednot on this map

Access to Pre-exposure Prophylaxis for Men Who Have Sex With Men: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

TypeinterventionalSponsorANRS, Emerging Infectious DiseasesRan2017 to 2021Enrolled649ConditionsHIV/AIDSArmsHIV prevention package including PrEP
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

August EubanksAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France. august.eubanks@inserm.fr.ORCID http://orcid.org/0000-0001-9197-1635
Bakary CoulibalyARCAD Santé PLUS, Bamako, Mali.
Bintou Dembélé KeitaARCAD Santé PLUS, Bamako, Mali.
Camille AnomaEspace Confiance, Abidjan, Côte d'Ivoire.
Ter Tiero Elias DahAssociation African Solidarité, Ouagadougou, Burkina Faso.
Ephrem MensahEspoir Vie Togo, Lomé, Togo.
Gwenaëlle MaradanAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
Michel BourrellyAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
Marion MoraAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
Lucas RiegelCoalition Plus, Community-Based Research Laboratory, Pantin, France.
Daniela Rojas CastroAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
Issifou YayaTransVIHMI, Univ Montpellier, INSERM, Montpellier, IRD, France.
Bruno SpireAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
Christian LaurentTransVIHMI, Univ Montpellier, INSERM, Montpellier, IRD, France.
Luis Sagaon-TeyssierAix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de L'Information Médicale, ISSPAM, Marseille, France.
and the COHMSM-PrEP Study Group
Inserm · FRMali-Folkecenter · MLCentre Muraz · BFEspoir Vie-Togo · TG

Funding

agence nationale de recherches sur le sida et les hépatites virales ANRS 12324-B99agence nationale de recherches sur le sida et les hépatites virales ANRS 12369agence nationale de recherches sur le sida et les hépatites virales ANRS 12369-B105Sidaction 2021-2-FJC-13012
6 · The paper itself

Abstract

We investigated the rate and predictors of ineffective HIV protection in men who have sex with men (MSM) taking pre-exposure prophylaxis (PrEP) in a prospective cohort study from November 2017 to November 2020 in Mali, Côte d'Ivoire, Burkina Faso, and Togo. MSM had to be 18 years or older and at high risk of HIV infection to participate. They also received a comprehensive sexual health prevention package, including PrEP, in community-based clinics as part of the cohort study. Using socio-behavioral/clinical data, HIV protection during their most recent anal intercourse with a male partner was categorized as effective or ineffective (i.e., incorrect PrEP adherence and no condom use). Seventeen percent (500/2839) of intercourses were ineffectively protected for the 520 study participants. Predictors of ineffective HIV protection included being an event-driven user with financial difficulties, having a high alcohol misuse score, and not being a member of a community association. PrEP programs in West Africa must be tailored to socially vulnerable MSM who struggle to adopt PrEP.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesBurkina FasoCohort StudiesHomosexuality, MaleHumansMaleProspective StudiesAnti-HIV AgentsCommunity-based researchHIVMSMPrEPWest Africa

Identifiers

PMID35469111
OpenAlexW4224311834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.